Q1 2025 Scientific Industries Inc Earnings Call Transcript
Key Points
- Scientific Industries Inc (SCND) successfully raised $1.5 million, enabling continued development of the SBI DOTS multiparameter sensor platform.
- The Genie brand products performed well, with a notable shift towards US-based customers.
- The company began shipping its first VIVID WORKSTATION, marking progress in AI-enabled pill counting technology.
- Scientific Industries Inc (SCND) reported a 17% reduction in quarterly cash demand, demonstrating effective cost control.
- Lead volume increased by 65% year over year, with over 300 new contracts added to the pipeline, indicating strong customer interest.
- The bioprocessing business segment experienced low revenues due to disruptions in financing and challenges in the academic markets.
- There was a $180,000 year-over-year revenue decline in the bioprocessing segment, primarily due to frozen academic grants and delayed start-up financing.
- The sales cycle for the mammalian cell culture market is longer, impacting revenue recognition.
- The first quarter was notably soft in terms of revenue generation, reflecting a broader slowdown in the bioprocessing tools and laboratory instrumentation sector.
- The company faces challenges in converting customer interest into closed orders due to prolonged budget cycles and conservative capital investment.
Good day, and welcome to the Scientific Industries first quarter fiscal year 2025 financial results conference call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Joe Dorame, Managing Partner. Please go ahead.
Thanks, Michael. Good morning, and thank you all for joining us today to review Scientific Industries First Quarter 2025 Financial Results for the period ended March 31, 2025. With us today on the call are Helena Santos, Chief Executive Officer; Daniel Donadille, CEO of SBI; and John Moore, Chairman. After the conclusion of today's prepared remarks, we'll open the call for questions.
Before we begin with prepared remarks, I would like to remind everyone certain statements made by the management team of Scientific Industries during this conference call constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Except for the statements of historical fact, this conference
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
